CIT is sponsored by the Chinese Medical Association, Chinese Society of Cardiology, Board of Directors, China Interventional Therapeutics (CIT) and partially funded from industrial supporters. The China Interventional Therapeutics (CIT) strives to ensure that its programs are as educational as possible and free from bias. To support this endeavor, CIT directors and co-directors create organizational and scientific committees to assist in educational content development and content oversight for live cases, concurrent sessions, case reviews, practical workshops, and scientific symposia. These sessions are developed without influence from industrial supporters.

For more information regarding how you can help to support CIT, please contact:

Kevin Chen
Manager, Exhibit Service
Tel: +86 10 8515 8150
E-mail: kevinchen@cma.org.cn

Disclosure
It is the policy of the China Interventional Therapeutics (CIT) to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational programs. Industrial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and, therefore, does not compromise the scientific integrity of the educational activity. Discussion of off-label product usage, and/or off-label product use during live or taped cases, is made at the sole discretion of the faculty and is not endorsed by the China Interventional Therapeutics (CIT) or the program directors for this activity.